90288 Botulism ig intravenous
Medicine
Also known as: BIG-IV, botulism IG, botulism immunoglobulin
Botulism immunoglobulin intravenous for passive immunotherapy of botulism in pediatric patients.
Clinical Context
FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.